Daily Archives: September 21, 2017

New FDA Directions – Part 3 – Opioids

In this third, and final installment on new directions for FDA under the watch of a new Commissioner, we turn to the issue of opioids. When Dr. Robert Califf was being considered for confirmation as FDA Commissioner he faced a … Continue reading

Posted in FDA Policy | 1 Comment